tiprankstipranks
Trending News
More News >
Idexx Laboratories (IDXX)
NASDAQ:IDXX
US Market

Idexx Laboratories (IDXX) Financial Statements

Compare
2,143 Followers

Idexx Laboratories Financial Overview

Idexx Laboratories's market cap is currently $45.69B. The company's EPS TTM is $3.08; its P/E ratio is 51.15; Idexx Laboratories is scheduled to report earnings on February 2, 2026, and the estimated EPS forecast is $3.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 4.30B$ 3.90B$ 3.66B$ 3.37B$ 3.22B
Gross Profit$ 2.66B$ 2.38B$ 2.19B$ 2.00B$ 1.89B
Operating Income$ 1.36B$ 1.13B$ 1.10B$ 898.76M$ 932.03M
EBITDA$ 1.47B$ 1.28B$ 1.22B$ 1.01B$ 1.04B
Net Income$ 1.06B$ 887.87M$ 845.04M$ 679.09M$ 744.85M
Balance Sheet
Cash & Short-Term Investments$ 180.07M$ 288.27M$ 453.93M$ 112.55M$ 144.45M
Total Assets$ 3.35B$ 3.29B$ 3.26B$ 2.75B$ 2.44B
Total Debt$ 1.08B$ 986.95M$ 1.07B$ 1.47B$ 1.03B
Net Debt$ 897.14M$ 698.68M$ 613.42M$ 1.36B$ 886.55M
Total Liabilities$ 1.75B$ 1.70B$ 1.78B$ 2.14B$ 1.75B
Stockholders' Equity$ 1.61B$ 1.60B$ 1.48B$ 608.74M$ 689.99M
Cash Flow
Free Cash Flow$ 1.05B$ 798.08M$ 772.88M$ 394.15M$ 636.00M
Operating Cash Flow$ 1.18B$ 929.00M$ 906.51M$ 542.98M$ 755.55M
Investing Cash Flow$ -136.24M$ -207.06M$ -125.25M$ -195.35M$ -292.97M
Financing Cash Flow$ -1.16B$ -878.07M$ -442.00M$ -370.94M$ -697.41M
Currency in USD

Idexx Laboratories Earnings and Revenue History

Idexx Laboratories Debt to Assets

Idexx Laboratories Cash Flow

Idexx Laboratories Forecast EPS vs Actual EPS